Sweet’s syndrome in the setting of newly initiated risankizumab therapy for pre-existing psoriasis | BMJ Case Reports

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Global health

Authors

About

Help
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Case Reports: Rare disease

Sweet’s syndrome in the setting of newly initiated risankizumab therapy for pre-existing psoriasis

Online download statistics by month:

Online download statistics by month: February 2022 to April 2024

	Abstract	Full	Pdf
Feb 2022	911	25	10
Mar 2022	731	28	23
Apr 2022	348	5	20
May 2022	220	7	6
Jun 2022	112	4	9
Jul 2022	112	4	4
Aug 2022	104	3	4
Sep 2022	138	3	5
Oct 2022	125	8	6
Nov 2022	109	8	5
Dec 2022	52	1	4
Jan 2023	39	5	3
Feb 2023	107	1	0
Mar 2023	61	2	6
Apr 2023	27	1	0
May 2023	137	1	5
Jun 2023	58	3	3
Jul 2023	63	5	5
Aug 2023	52	0	1
Sep 2023	84	1	3
Oct 2023	48	0	0
Nov 2023	54	4	4
Dec 2023	54	3	7
Jan 2024	11	0	0
Feb 2024	69	0	0
Mar 2024	32	2	7
Apr 2024	27	0	0
Total	3885	124	140